Spero Therapeutics Inc (SPRO)
0.9597
-0.04
(-3.84%)
USD |
NASDAQ |
Dec 20, 16:00
0.9598
0.00 (0.00%)
After-Hours: 06:27
Spero Therapeutics Total Liabilities (Quarterly): 69.65M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CytomX Therapeutics Inc | 162.43M |
| Castle Biosciences Inc | 73.51M |
| Arbutus Biopharma Corp | 33.55M |
| PTC Therapeutics Inc | 2.897B |
| Equillium Inc | 11.28M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 135.16M |
| Shareholders Equity (Quarterly) | 65.51M |
| Current Ratio | 2.681 |